NG
MDT icon

Novem Group’s Medtronic MDT Stock Holding History

Novem Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$599K Sell
7,660
-31,931
-81% -$2.58M 0.06% 252
2026
Q1 		$3.43M Buy
39,591
+715
+2% +$68.5K 0.39% 63
2025
Q4 		$3.73M Sell
38,876
-1,202
-3% -$117K 0.43% 57
2025
Q3 		$3.82M Sell
40,078
-707
-2% -$65K 0.45% 49
2025
Q2 		$3.56M Buy
40,785
+929
+2% +$78.8K 0.45% 53
2025
Q1 		$3.58M Buy
39,856
+3,749
+10% +$335K 0.5% 45
2024
Q4 		$2.88M Buy
+36,107
New +$3.13M 0.42% 60

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Novem Group's MDT Position: Q2 2026 in Review

Novem Group reduced its Medtronic (MDT) stake by 81% in Q2 2026, selling an estimated $2.58M and leaving 7,660 shares worth $599K. The position accounts for 0.06% of the portfolio, ranked #252.

Novem Group first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.82M in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Novem Group held 7,660 shares of Medtronic worth $599K as of Q2 2026.
  • Novem Group sold 31,931 Medtronic shares in Q2 2026, an estimated $2.58M.
  • Medtronic made up 0.06% of Novem Group's portfolio in Q2 2026, its #252 holding.
  • Novem Group first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Medtronic position peaked at $3.82M in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.